Abstract

Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for the evaluation of liver disease severity and prognosis, focusing on the topics for which relevant evidence has been published in the last 5 years.

Keywords

Clinical PracticeMedicineDiseaseLiver diseaseIntensive care medicineInternal medicineFamily medicine

MeSH Terms

Elasticity Imaging TechniquesEuropeGastroenterologyHumansLiverLiver DiseasesPrognosisSeverity of Illness Index

Affiliated Institutions

Related Publications

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Naga Chalasani , Zobair M. Younossi , Joel E. Lavine +5 more

These recommendations are based on the following: (1) a formal review and analysis of the recently published world literature on the topic [Medline search up to June 2011]; (2) ...

2012 Hepatology 3765 citations

Publication Info

Year
2021
Type
article
Volume
75
Issue
3
Pages
659-689
Citations
1496
Access
Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1496
OpenAlex
39
Influential
1399
CrossRef

Cite This

Annalisa Berzigotti, Emmanuel Tsochatzis, Jérôme Boursier et al. (2021). EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. Journal of Hepatology , 75 (3) , 659-689. https://doi.org/10.1016/j.jhep.2021.05.025

Identifiers

DOI
10.1016/j.jhep.2021.05.025
PMID
34166721

Data Quality

Data completeness: 86%